HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lars-Ove Brandenburg Selected Research

Formyl Peptide Receptors (Formyl Peptide Receptor)

12/2021The N-Formyl Peptide Receptor 2 (FPR2) Agonist MR-39 Improves Ex Vivo and In Vivo Amyloid Beta (1-42)-Induced Neuroinflammation in Mouse Models of Alzheimer's Disease.
10/2020The formyl peptide receptor agonist Ac2-26 alleviates neuroinflammation in a mouse model of pneumococcal meningitis.
4/2020Inhibition of formyl peptide receptors improves the outcome in a mouse model of Alzheimer disease.
6/2017Formyl Peptide Receptor 1-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination.
11/2014Lack of formyl peptide receptor 1 and 2 leads to more severe inflammation and higher mortality in mice with of pneumococcal meningitis.
1/2014Deficiency of formyl peptide receptor 1 and 2 is associated with increased inflammation and enhanced liver injury after LPS-stimulation.
11/2012Involvement of formyl peptide receptors in receptor for advanced glycation end products (RAGE)--and amyloid beta 1-42-induced signal transduction in glial cells.
2/2011The formyl peptide receptor like-1 and scavenger receptor MARCO are involved in glial cell activation in bacterial meningitis.
8/2009Involvement of Phospholipase D 1 and 2 in the subcellular localization and activity of formyl-peptide-receptors in the human colonic cell line HT29.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lars-Ove Brandenburg Research Topics

Disease

12Inflammation (Inflammations)
01/2022 - 08/2009
10Bacterial Meningitis
11/2018 - 11/2008
8Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis)
10/2020 - 02/2013
7Alzheimer Disease (Alzheimer's Disease)
12/2021 - 06/2008
6Neuroinflammatory Diseases
12/2021 - 07/2008
6Muscle Cramp (Cramp)
01/2017 - 02/2011
5Infections
10/2020 - 02/2011
5Meningitis
10/2020 - 11/2008
5Prostatic Neoplasms (Prostate Cancer)
10/2019 - 01/2016
4Neoplasms (Cancer)
01/2019 - 03/2016
4Bacterial Infections (Bacterial Infection)
02/2013 - 12/2009
3Porcine Reproductive and Respiratory Syndrome (PRRS)
11/2019 - 06/2017
3Demyelinating Diseases (Demyelinating Disease)
08/2018 - 04/2010
3Neurodegenerative Diseases (Neurodegenerative Disease)
11/2012 - 05/2010
2Gliosis
08/2018 - 01/2017
2Meningococcal Meningitis
01/2017 - 02/2011
1Body Weight (Weight, Body)
10/2020
1Amyloid Plaque
04/2020
1Leiomyosarcoma
10/2019
1Carcinoma (Carcinomatosis)
10/2019
1Endometrial Neoplasms (Endometrial Cancer)
10/2019
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
12/2017
1Memory Disorders (Memory Loss)
01/2017
1Liver Diseases (Liver Disease)
01/2015
1Fibrosis (Cirrhosis)
01/2015
1Carcinogenesis
07/2014
1Virus Diseases (Viral Diseases)
05/2013
1Mitochondrial Diseases (Mitochondrial Disease)
03/2012
1Hepatitis
02/2011
1Multiple Sclerosis
04/2010

Drug/Important Bio-Agent (IBA)

12CytokinesIBA
01/2021 - 01/2010
11Antimicrobial PeptidesIBA
01/2017 - 11/2008
9Formyl Peptide Receptors (Formyl Peptide Receptor)IBA
12/2021 - 08/2009
9CathelicidinsIBA
01/2017 - 11/2008
5Pattern Recognition ReceptorsIBA
11/2019 - 02/2013
4CuprizoneIBA
08/2018 - 04/2010
4Messenger RNA (mRNA)IBA
06/2017 - 02/2013
3MicroRNAs (MicroRNA)IBA
01/2022 - 08/2016
3Peptides (Polypeptides)IBA
10/2020 - 01/2010
3ChemokinesIBA
11/2018 - 08/2015
3G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
11/2012 - 05/2010
2Amyloid (Amyloid Fibrils)IBA
12/2021 - 04/2020
2Amyloid beta-PeptidesIBA
12/2021 - 06/2008
2InflammasomesIBA
01/2021 - 12/2012
2Annexin A1IBA
10/2020 - 11/2019
2AndrogensIBA
01/2019 - 01/2016
2S100 Calcium Binding Protein A7IBA
01/2017 - 05/2013
2Biomarkers (Surrogate Marker)IBA
01/2017 - 10/2016
2Interleukin-6 (Interleukin 6)IBA
01/2016 - 02/2011
2Scavenger Receptors (Scavenger Receptor)IBA
02/2011 - 05/2010
1Macrophage Colony-Stimulating FactorIBA
11/2019
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
11/2019
1Steroid Receptors (Steroid Receptor)IBA
10/2019
1enzalutamideIBA
10/2019
1Heat-Shock Proteins (Heat-Shock Protein)IBA
10/2019
1Androgen Receptor AntagonistsIBA
10/2019
1Androgen Receptors (Androgen Receptor)IBA
10/2019
1Estrogen ReceptorsIBA
10/2019
1matrigelIBA
01/2019
1Chemokine CCL3IBA
11/2018
1Toll-Like Receptors (Toll-Like Receptor)IBA
08/2018
1GTP-Binding Proteins (G-Protein)IBA
06/2017
1Peptidoglycan (Murein)IBA
01/2017
1methysticinIBA
01/2017
1Interleukin-17 (Interleukin 17)IBA
01/2017
1LipopolysaccharidesIBA
01/2017
1Toll-Like Receptor 2IBA
10/2016
1Proteins (Proteins, Gene)FDA Link
03/2016
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2016
1HSP27 Heat-Shock ProteinsIBA
01/2016
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2016
1Type I Tumor Necrosis Factor ReceptorsIBA
01/2016
1Abiraterone AcetateIBA
01/2016
1Choline (Choline Chloride)IBA
01/2015
1Methionine (L-Methionine)FDA Link
01/2015
1CollagenIBA
01/2015
1Complement C5a (Complement 5a)IBA
01/2015
11-dodecylpyridoxal (PLD)IBA
07/2014
1Double-Stranded RNA (RNA, Double Stranded)IBA
05/2013
1Poly I-CIBA
05/2013
1CytosineIBA
02/2013
1DNA (Deoxyribonucleic Acid)IBA
02/2013
1Bacterial DNAIBA
02/2013
1GuanineIBA
02/2013
1OligodeoxyribonucleotidesIBA
02/2013
1Mitogen-Activated Protein KinasesIBA
02/2013
1Toll-Like Receptor 9IBA
02/2013
1LigandsIBA
11/2012
1Receptor for Advanced Glycation End ProductsIBA
11/2012
1Oxidants (Oxidizing Agents)IBA
03/2012
1Transcription Factors (Transcription Factor)IBA
02/2011
1sulforaphaneIBA
06/2010
1activin AIBA
01/2010
1Prion ProteinsIBA
11/2009

Therapy/Procedure

3Therapeutics
10/2020 - 08/2015
2Intraventricular Infusions
08/2015 - 02/2013
1Intraperitoneal Injections
10/2020
1Oral Administration
01/2017
1Ligation
01/2015
1Aftercare (After-Treatment)
02/2013